Pharma and Biotech
| Latest | F'cast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | n/a | n/a |
| ROCE | 393.8% |
| Latest | F'cast | |
|---|---|---|
| P/E | n/a | n/a |
| PEG | n/a | n/a |
| Pr/Revenue | n/a | n/a |
| Pr/Book | n/a |
| Latest | F'cast | |
|---|---|---|
| Revenue | n/a | n/a |
| PBT | n/a | n/a |
| EPS | n/a | n/a |
| DPS | n/a | n/a |
| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-21 | n/a | (0.99) | (0.59)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-22 | n/a | (1.34) | (0.46)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-23 | n/a | (1.86) | (0.64)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-24 | n/a | (1.59) | (0.47)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
| Holding(s) in Company | 24-Oct-2025 | 07:00 | RNS |
| Second European Patent Application | 22-Oct-2025 | 07:00 | RNS |
| Recognition of Patentability of Claims | 20-Oct-2025 | 07:00 | RNS |
No recent information was found.
| Traded | Action | Notifier | Price | Amount | Value |
|---|---|---|---|---|---|
| 08-Oct-25 | Placing | Eric Leire | 1.10p | 40,000,000 | £440,000.00 |
| Currency | UK Pounds |
| Share Price | 2.20p |
| Change Today | 0.050p |
| % Change | 2.33 % |
| 52 Week High | 2.40 |
| 52 Week Low | 0.62 |
| Volume | 5,044,275 |
| Shares Issued | 493.55m |
| Market Cap | £10.86m |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth | ![]() |
|---|
| No dividends found |
| Time | Volume / Share Price |
| 16:09 | 21,392 @ 2.27p |
| 15:56 | 30,241 @ 2.27p |
| 15:54 | 1,200 @ 2.10p |
| 15:54 | 200,000 @ 2.17p |
| 15:51 | 21,421 @ 2.27p |
You are here: research